Description
p.Arg1648Leu (CGT>CTT): c.4943 G>T in exon 26 of the SCN1A gene (NM_001165963.1) The Arg1648Leu missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The NHLBI ESP Exome Variant Project has not identified Arg1648Leu in approximately 6,500 individuals of European or African American ethnicity, indicating that it is not a common benign variant in these populations. The amino acid substitution is non-conservative, as a positively charged Arginine residue is replaced by an uncharged, non-polar Leucine residue. It alters a highly conserved position in the S4 (voltage sensor) segment of the fourth transmembrane domain, and multiple in silico algorithms predict it is damaging to protein structure/function. Additionally, a different amino acid substitution at the same amino acid position, Arg1648Cys, was found to co-segregate with GEFS+ in a large family and was also reported in an individual with Dravet syndrome (Ohmori et al., 2002). Another substitution at that position, Arg1648His, has been reported multiple times in association with Dravet syndrome, and functional studies indicate that it significantly impairs channel function (Escayg et al., 2000; Depienne et al., 2009; Alekov et al., 2000; Tang et al., 2009). Therefore, Arg1648Leu is considered a disease-causing mutation. The variant is found in EPILEPSY panel(s).
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | yes | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |